ArticleNature communications2024

A unifying model to explain frequent SARS-CoV-2 rebound after nirmatrelvir treatment and limited prophylactic efficacy.

Shadisadat Esmaeili et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.